Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 10, 2019
The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN)
Sarah Perreault, Dayna McManus, Noffar Bar, et al.
Transfusion
|
March 5, 2020
Investigation of increased platelet alloimmunization screening in the era of pathogen-reduced platelets treated with psoralen/UV light
Jeanne E Hendrickson, Hadrian Mendoza, Rebecca Ross, et al.
Blood Advances
|
November 7, 2022
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
Kunal C Potnis, Mengyang Di, Iris Isufi, et al.
Leukemia & Lymphoma
|
April 4, 2019
Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations
Rory M Shallis, Shana Gleeson, Marwan M Azar, et al.
Leukemia & Lymphoma
|
December 21, 2020
A case of acute myeloid leukemia with unusual germline <i>CEBPA</i> mutation: lessons learned about mutation detection, location, and penetrance
Hadrian Mendoza, Po-Han Chen, Alexander B Pine, et al.
Transplantation and Cellular Therapy
|
September 22, 2021
Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-Analysis
Jan Philipp Bewersdorf, Cecily Allen, Abu-Sayeef Mirza, et al.
Transplantation and Cellular Therapy
|
May 30, 2021
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-Analysis
Jan Philipp Bewersdorf, Amar H Sheth, Shaurey Vetsa, et al.
Leukemia & Lymphoma
|
May 5, 2020
Clinical outcomes and characteristics of patients with <i>TP53</i>-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience
Jan Philipp Bewersdorf, Rory M Shallis, Lohith Gowda, et al.
Blood Advances
|
July 28, 2025
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AML
Abdulrahman Alhajahjeh, Kishan Patel, Nikolai A Podoltsev, et al.
Transplantation and Cellular Therapy
|
October 10, 2025
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research Analysis
Nosha Farhadfar, Stephanie Bo-Subait, Gabrielle Schmidt, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 10, 2019
The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN)
Sarah Perreault, Dayna McManus, Noffar Bar, et al.
Transfusion
|
March 5, 2020
Investigation of increased platelet alloimmunization screening in the era of pathogen-reduced platelets treated with psoralen/UV light
Jeanne E Hendrickson, Hadrian Mendoza, Rebecca Ross, et al.
Blood Advances
|
November 7, 2022
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
Kunal C Potnis, Mengyang Di, Iris Isufi, et al.
Leukemia & Lymphoma
|
April 4, 2019
Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations
Rory M Shallis, Shana Gleeson, Marwan M Azar, et al.
Leukemia & Lymphoma
|
December 21, 2020
A case of acute myeloid leukemia with unusual germline <i>CEBPA</i> mutation: lessons learned about mutation detection, location, and penetrance
Hadrian Mendoza, Po-Han Chen, Alexander B Pine, et al.
Transplantation and Cellular Therapy
|
September 22, 2021
Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-Analysis
Jan Philipp Bewersdorf, Cecily Allen, Abu-Sayeef Mirza, et al.
Transplantation and Cellular Therapy
|
May 30, 2021
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-Analysis
Jan Philipp Bewersdorf, Amar H Sheth, Shaurey Vetsa, et al.
Leukemia & Lymphoma
|
May 5, 2020
Clinical outcomes and characteristics of patients with <i>TP53</i>-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience
Jan Philipp Bewersdorf, Rory M Shallis, Lohith Gowda, et al.
Blood Advances
|
July 28, 2025
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AML
Abdulrahman Alhajahjeh, Kishan Patel, Nikolai A Podoltsev, et al.
Transplantation and Cellular Therapy
|
October 10, 2025
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research Analysis
Nosha Farhadfar, Stephanie Bo-Subait, Gabrielle Schmidt, et al.
Page
of 6